Clinical Trial Update: Study of Carfilzomib in Combination With Induction Chemotherapy in Children With Relapsed or Refractory Acute Lymphoblastic Leukemia [Phase 1]

View source ↗

Summary

Phase 1 trial results update for carfilzomib in combination with induction chemotherapy in children with relapsed or refractory acute lymphoblastic leukemia. Th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Drugs mentioned

• Carfilzomib (carfilzomib)

Snippet

Sponsor: Amgen | Conditions: Acute Lymphoblastic Leukemia (ALL) | Phase 1 | Status: COMPLETED | Results posted: 2025-06-04